dn 1417 has been researched along with cytarabine in 1 studies
| Studies (dn 1417) | Trials (dn 1417) | Recent Studies (post-2010) (dn 1417) | Studies (cytarabine) | Trials (cytarabine) | Recent Studies (post-2010) (cytarabine) |
|---|---|---|---|---|---|
| 94 | 2 | 0 | 15,487 | 2,424 | 3,188 |
| Protein | Taxonomy | dn 1417 (IC50) | cytarabine (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 7.533 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imura, H; Kato, Y; Tatsuoka, Y | 1 |
1 other study(ies) available for dn 1417 and cytarabine
| Article | Year |
|---|---|
Effect of DN-1417, a synthetic thyrotropin-releasing hormone analogue, on [3H]GABA binding in the cerebellum of ataxic rats.
Topics: Animals; Cerebellar Ataxia; Cerebellum; Cerebral Cortex; Cytarabine; gamma-Aminobutyric Acid; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A; Thyrotropin-Releasing Hormone | 1985 |